documents: FDA-2022-N-2390-0022

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2390-0022 FDA FDA-2022-N-2390 Proposed Order RE: Proposal To Refuse To Approve a New Drug Application Supplement for HETLIOZ (Tasimelteon); Opportunity for a Hearing Supporting & Related Material Background Material 2023-06-22T04:00:00Z 2023 6     2023-06-22T14:42:13Z   0 0 0900006485bb0f98

Links from other tables